Korean J Med.  2011 May;80(5):588-594.

A Case of Pulmonary Alveolar Proteinosis that Improved with GM-CSF Inhalation Therapy

Affiliations
  • 1Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. mp.chung@samsung.com

Abstract

Pulmonary alveolar proteinosis (PAP) is a rare condition that is treated using whole lung lavage. A recent study suggested that granulocyte-macrophage colony stimulating factor (GM-CSF) plays roles in both the pathogenesis and treatment of PAP. We present a 69-year-old man with PAP who deteriorated despite bilateral whole lung lavage; that said, his symptoms, chest X-ray findings, and pulmonary function test improved after GM-CSF inhalation therapy over 12 months. GM-CSF therapy is an effective treatment modality for PAP.

Keyword

Pulmonary alveolar proteinosis; Bronchoalveolar lavage; GM-CSF

MeSH Terms

Aged
Bronchoalveolar Lavage
Colony-Stimulating Factors
Granulocyte-Macrophage Colony-Stimulating Factor
Humans
Inhalation
Lung
Pulmonary Alveolar Proteinosis
Respiratory Function Tests
Respiratory Therapy
Thorax
Colony-Stimulating Factors
Granulocyte-Macrophage Colony-Stimulating Factor
Full Text Links
  • KJM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr